Novo Seeds
Great ideas need nurture and know-how to grow strong
Novo Ventures
An active partner with an international platform and long-term commitment
Novo Growth Equity
Creating value by holding rather than by exiting
Novo Finance
Financial investments based on a clear investment philosophy
Novo press release
Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million.
Click here to read the press release.
News
- Cardeas Pharma Completes $34 Million in Series B Financing
- European Medicines Agency (EMA) Accepts Veloxis’ Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients
- Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million